Adrian Johnson

TLDR: Capstan Therapeutics, a biotechnology company, raised $175M in Series B funding to advance its lead in vivo CAR-T candidate and further develop its tLNP pipeline. The funding round was led by

TLDR: AccessPay, a bank integration provider based in Manchester, UK, has raised $24M in Strategic funding. The funding round was led by True Ventures, with participation from other investors. AccessPay, led by

TLDR: AccessPay, a Manchester-based FinTech company, has secured £19 million in funding. The funding round was led by True Ventures, a Silicon Valley-based VC firm. AccessPay, a FinTech 50 star, has closed

TLDR: Key Points: Cedar Capital marks First Close of debut FinTech Venture Capital fund BankTech to be a key focus Sahil Anand-led Cedar Capital, a FinTech-focused Venture Capital fund, has successfully closed

TLDR: NovaData Solutions, a provider of AI-driven software for property restoration invoice analysis, raised Series A funding led by Activate Venture Partners. The funding will be used to enhance software capabilities, expand

TLDR: Key Points: Engrail Therapeutics has secured USD 157 million in Series B funding led by F-Prime Capital, Forbion, and Norwest Venture Partners. The funding will support the advancement of the company’s

Article Summary TLDR: OTB Ventures closes a new €170 million fund to support European deeptech startups Fund 2 will focus on SpaceTech, Enterprise Automation & AI, Cybersecurity, and FinTech Infrastructure Amsterdam-based OTB

TLDR: Immutable, King River Capital, and Polygon Labs have set up a USD 100 million “Inevitable Games Fund” for Web3 gaming opportunities Alpha Wave Ventures, Merit Circle, Mike Arrington, and Steve Kokinos

TLDR: Ultrahuman, a wearable healthtech startup, raised USD 35 million in Series B funding. The funds will be used to enhance manufacturing capacity and conduct deeper research in the health tracking space.

TLDR: Ukrainian investment group Roosh partners with Canadian startup builder Tiny Studio to challenge private equity orthodoxy in Europe. Roosh’s investment wing Roosh X will deploy funding from $500,000 to $10m to